• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P2Y(1)受体对修饰腺嘌呤核苷酸的分子识别。1. 一种合成、生化和核磁共振方法。

Molecular recognition of modified adenine nucleotides by the P2Y(1)-receptor. 1. A synthetic, biochemical, and NMR approach.

作者信息

Halbfinger E, Major D T, Ritzmann M, Ubl J, Reiser G, Boyer J L, Harden K T, Fischer B

机构信息

Department of Chemistry, Gonda-Goldschmied Center, Bar-Ilan University, Ramat-Gan 52900, Israel.

出版信息

J Med Chem. 1999 Dec 30;42(26):5325-37. doi: 10.1021/jm990156d.

DOI:10.1021/jm990156d
PMID:10639276
Abstract

The remarkably high potencies of 2-thioether-adenine nucleotides regarding the activation of the P2Y(1)-receptor (P2Y(1)-R) in turkey erythrocyte membranes represent some of the largest substitution-promoted increases in potencies over that of a natural receptor ligand. This paper describes the investigation regarding the origin of the high potency of these P2Y(1)-R ligands over that of ATP. For this study, an integrated approach was employed combining the synthesis of new ATP analogues, their biochemical evaluation, and their SAR analysis involving NMR experiments and theoretical calculations. These experiments and calculations were performed to elucidate the conformation and to evaluate the electronic nature of the investigated P2Y(1)-R ligands. ATP analogues synthesized included derivatives where C2 or C8 positions were substituted with electron-donating groups such as ethers, thioethers, or amines. The compounds were tested for their potency to induce P2Y(1)-R-mediated activation of phospholipase C in turkey erythrocytes and Ca(2+) response in rat astrocytes. 8-Substituted ATP and AMP derivatives had little or no effect on phospholipase C or on calcium levels, whereas the corresponding 2-substituted ATP analogues potently increased the levels of inositol phosphates and ¿Ca(2+)(i). AMP analogues were ineffective except for 2-butylthio-AMP which induced a small Ca(2+) response. P2Y(1)-R activity of these compounds was demonstrated by testing these ligands also on NG108-15 neuroblastoma x glioma hybrid cells. NMR data together with theoretical calculations imply that steric, rather than electronic, effects play a major role in ligand binding to the P2Y(1)-R. Hydrophobic interactions and H-bonds of the C2 substituent appear to be important determinants of a P2Y(1)-R ligand affinity.

摘要

2-硫醚腺嘌呤核苷酸对火鸡红细胞膜中P2Y(1)受体(P2Y(1)-R)的激活具有极高的效力,相较于天然受体配体,这代表了一些因取代作用而导致效力提升最为显著的情况。本文描述了对这些P2Y(1)-R配体相较于ATP具有高效力的起源的研究。在本研究中,采用了一种综合方法,将新的ATP类似物的合成、它们的生化评估以及涉及NMR实验和理论计算的构效关系分析相结合。进行这些实验和计算是为了阐明所研究的P2Y(1)-R配体的构象并评估其电子性质。合成的ATP类似物包括C2或C8位置被供电子基团(如醚、硫醚或胺)取代的衍生物。测试了这些化合物在火鸡红细胞中诱导P2Y(1)-R介导的磷脂酶C激活以及在大鼠星形胶质细胞中引发Ca(2+)反应的效力。8-取代的ATP和AMP衍生物对磷脂酶C或钙水平几乎没有影响,而相应的2-取代的ATP类似物则显著提高了肌醇磷酸和Ca(2+)的水平。除了2-丁硫基-AMP能诱导小的Ca(2+)反应外,AMP类似物均无效。通过在NG108-15神经母细胞瘤x胶质瘤杂交细胞上测试这些配体,证实了这些化合物的P2Y(1)-R活性。NMR数据与理论计算表明,空间效应而非电子效应在配体与P2Y(1)-R的结合中起主要作用。C2取代基的疏水相互作用和氢键似乎是P2Y(1)-R配体亲和力的重要决定因素。

相似文献

1
Molecular recognition of modified adenine nucleotides by the P2Y(1)-receptor. 1. A synthetic, biochemical, and NMR approach.P2Y(1)受体对修饰腺嘌呤核苷酸的分子识别。1. 一种合成、生化和核磁共振方法。
J Med Chem. 1999 Dec 30;42(26):5325-37. doi: 10.1021/jm990156d.
2
Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate.强效、选择性P2Y嘌呤受体激动剂的鉴定:三磷酸腺苷5'-硫醚衍生物的构效关系
J Med Chem. 1993 Nov 26;36(24):3937-46. doi: 10.1021/jm00076a023.
3
Potent agonist action of 2-thioether derivatives of adenine nucleotides at adenylyl cyclase-linked P2Y-purinoceptors.腺嘌呤核苷酸的2-硫醚衍生物对腺苷酸环化酶偶联的P2Y嘌呤受体具有强效激动作用。
Br J Pharmacol. 1995 Nov;116(6):2611-6. doi: 10.1111/j.1476-5381.1995.tb17215.x.
4
Molecular recognition of modified adenine nucleotides by the P2Y(1)-receptor. 2. A computational approach.
J Med Chem. 1999 Dec 30;42(26):5338-47. doi: 10.1021/jm9901576.
5
Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.锁定在北方甲碳环构象的腺嘌呤核苷酸类似物:作为P2Y(1)受体激动剂时稳定性和效力增强。
J Med Chem. 2002 May 9;45(10):2090-100. doi: 10.1021/jm010538v.
6
2-Thioether-5'-O-(1-thiotriphosphate)-adenosine derivatives: new insulin secretagogues acting through P2Y-receptors.2-硫醚-5'-O-(1-硫代三磷酸)-腺苷衍生物:通过P2Y受体起作用的新型胰岛素促分泌剂。
Isr Med Assoc J. 2000 Jul;2 Suppl:92-8.
7
Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands.核糖修饰的脱氧腺苷二磷酸类似物作为P2Y(1)受体配体的合成、生物活性及分子模拟
J Med Chem. 2000 Mar 9;43(5):829-42. doi: 10.1021/jm990249v.
8
Novel modified adenosine 5'-triphosphate analogues pharmacologically characterized in human embryonic kidney 293 cells highly expressing rat brain P2Y(1) receptor: Biotinylated analogue potentially suitable for specific P2Y(1) receptor isolation.
Biochem Pharmacol. 2001 May 15;61(10):1259-69. doi: 10.1016/s0006-2952(01)00593-7.
9
Identification of competitive antagonists of the P2Y1 receptor.P2Y1受体竞争性拮抗剂的鉴定。
Mol Pharmacol. 1996 Nov;50(5):1323-9.
10
Two subtypes of G protein-coupled nucleotide receptors, P2Y(1) and P2Y(2) are involved in calcium signalling in glioma C6 cells.G蛋白偶联核苷酸受体的两种亚型,P2Y(1)和P2Y(2),参与了胶质瘤C6细胞中的钙信号传导。
Br J Pharmacol. 2001 Jan;132(2):393-402. doi: 10.1038/sj.bjp.0703843.

引用本文的文献

1
Synthesis, Characterization, Interactions, and Immunomodulatory Function of Ectonucleotidase CD39/CD73 Inhibitor 8-Butylthioadenosine 5'-Monophosphate.胞外核苷酸酶CD39/CD73抑制剂8-丁硫基腺苷5'-单磷酸的合成、表征、相互作用及免疫调节功能
ACS Pharmacol Transl Sci. 2025 Apr 3;8(5):1401-1415. doi: 10.1021/acsptsci.5c00126. eCollection 2025 May 9.
2
Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors.核苷酸类似物ARL67156作为开发CD39和双CD39/CD73胞外核苷酸酶抑制剂的先导结构。
Front Pharmacol. 2020 Sep 8;11:1294. doi: 10.3389/fphar.2020.01294. eCollection 2020.
3
New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors.
对血小板P2Y1和P2Y12二磷酸腺苷受体具有双重特异性的新型高活性抗血小板药物。
Eur J Med Chem. 2016 Jan 1;107:204-18. doi: 10.1016/j.ejmech.2015.10.055. Epub 2015 Nov 9.
4
Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold.基于腺苷 5'-(α 或 γ)-硫-(α,β-或 β,γ)-亚甲基三磷酸骨架的高活性和选择性的核苷酸焦磷酸酶/磷酸二酯酶 I 抑制剂。
J Med Chem. 2014 Jun 12;57(11):4677-91. doi: 10.1021/jm500196c. Epub 2014 May 30.
5
Synthesis of oxygen-linked 8-phenoxyl-deoxyguanosine nucleoside analogues.氧连接的8-苯氧基-脱氧鸟苷核苷类似物的合成。
European J Org Chem. 2011 Jun;2011(16). doi: 10.1002/ejoc.201100013.
6
8-BuS-ATP derivatives as specific NTPDase1 inhibitors.8-BuS-ATP 衍生物作为特异性 NTPDase1 抑制剂。
Br J Pharmacol. 2013 May;169(1):179-96. doi: 10.1111/bph.12135.
7
Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist.基于 P2Y(1) 受体激动剂鉴定治疗 2 型糖尿病的有前途的药物候选物。
J Med Chem. 2012 Sep 13;55(17):7623-35. doi: 10.1021/jm3006355. Epub 2012 Aug 20.
8
Pharmacochemistry of the platelet purinergic receptors.血小板嘌呤能受体的药物化学。
Purinergic Signal. 2011 Sep;7(3):305-24. doi: 10.1007/s11302-011-9216-0. Epub 2011 Feb 18.
9
Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).功能化同系物方法设计 G 蛋白偶联受体 (GPCR) 的配体。
Bioconjug Chem. 2009 Oct 21;20(10):1816-35. doi: 10.1021/bc9000596. Epub 2009 Apr 30.
10
Development of selective agonists and antagonists of P2Y receptors.P2Y 受体选择性激动剂和拮抗剂的研制。
Purinergic Signal. 2009 Mar;5(1):75-89. doi: 10.1007/s11302-008-9106-2. Epub 2008 Jul 4.